Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Wheeler, J, Kim, H, Efstathiou, J, Ilyas, M, Mortensen, N, Bodmer, W
Format:	Journal article
Published:	2001

Similar Items

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
by: Wheeler, J, et al.
Published: (2001)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers.
by: Wheeler, J, et al.
Published: (2000)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI plus sporadic colorectal cancers
by: Wheeler, J, et al.
Published: (2000)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus sporadic RER plus colorectal cancers
by: Wheeler, J, et al.
Published: (2000)

E-cadherin mutations in human colorectal cancer cell lines
by: Wheeler, J, et al.
Published: (1999)

E-cadherin mutations in human colorectal cancer cell lines
by: Wheeler, J, et al.
Published: (1999)

The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.
by: Kim, H, et al.
Published: (2000)

Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.
by: Ilyas, M, et al.
Published: (1996)

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer
by: Porter, T, et al.
Published: (2002)

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
by: Porter, T, et al.
Published: (2002)

Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
by: Segditsas, S, et al.
Published: (2008)

Cancer surveillance in ulcerative colitis.
by: Chambers, WM, et al.
Published: (2005)

Metaplastic Paneth cells in ulcerative colitis and colorectal cancer
by: Osborne, C, et al.
Published: (2003)

Metaplastic Paneth cells in ulcerative colitis and colorectal cancer
by: Osborne, C, et al.
Published: (2003)

Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.
by: Ilyas, M, et al.
Published: (1997)

Predicting outcome in severe ulcerative colitis.
by: Travis, S, et al.
Published: (1996)

Ulcerative colitis.
by: Jewell, D
Published: (1975)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
by: Rowan, A, et al.
Published: (2000)

Pemphigoid and ulcerative colitis.
by: Barth, J, et al.
Published: (1988)

Infliximab for ulcerative colitis.
by: Simmons, J, et al.
Published: (2002)

Genetics of ulcerative colitis.
by: Satsangi, J, et al.
Published: (1996)

Ulcerative colitis in Malaysians
by: Pailoor, Jayalakshmi, et al.
Published: (1996)

Aetiopathogenesis of ulcerative colitis.
by: Jewell, D
Published: (1987)

Azathioprine in ulcerative colitis.
by: Jewell, D, et al.
Published: (1972)

Ulcerative colitis and sarcoidosis.
by: Barr, G, et al.
Published: (1986)

Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells.
by: Efstathiou, J, et al.
Published: (1999)

Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
by: Lessi, F, et al.
Published: (2010)

Promoter hypermethylation identifies progression risk in bladder cancer.
by: Yates, DR, et al.
Published: (2007)

E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis.
by: Siddiqui, K, et al.
Published: (2010)

Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease.
by: Samarasekera, D, et al.
Published: (1996)

Treatment of severe ulcerative colitis
by: Weersma, R, et al.
Published: (2006)

[Treatment of servere ulcerative colitis]
by: Weersma, R, et al.
Published: (2006)

Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.
by: Homfray, T, et al.
Published: (1998)

Reaginic hypersensitivity in ulcerative colitis.
by: Jewell, D, et al.
Published: (1972)

Olsalazine in active ulcerative colitis.
by: Selby, W, et al.
Published: (1985)

Ulcerative colitis and HLA phenotype.
by: Cottone, M, et al.
Published: (1985)

Drug therapy of ulcerative colitis.
by: Crotty, B, et al.
Published: (1992)

Disodium azodisalicylate in ulcerative colitis.
by: Jewell, D, et al.
Published: (1981)

Proceedings: Etiology of ulcerative colitis.
by: Jewell, D
Published: (1973)

Oral methotrexate in ulcerative colitis.
by: Cummings, JR, et al.
Published: (2005)